Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 16,912 | 15,391 | 16,839 | 18,757 | 14,262 |
| Operating Income | -16,912 | -15,391 | -16,839 | -18,757 | -14,262 |
| Other Income | 540 | 130 | -45 | 3 | -18 |
| Pre-tax Income | -16,372 | -15,261 | -16,884 | -18,754 | -14,280 |
| Net Income Continuous | -16,372 | -15,261 | -16,884 | -18,754 | -14,280 |
| Net Income | $-16,372 | $-15,261 | $-16,884 | $-18,754 | $-14,280 |
| EPS Basic Total Ops | -0.38 | -0.38 | -0.71 | -0.80 | -0.60 |
| EPS Basic Continuous Ops | -0.38 | -0.38 | -0.71 | -0.79 | -0.60 |
| EPS Diluted Total Ops | -0.38 | -0.38 | -0.71 | -0.80 | -0.60 |
| EPS Diluted Continuous Ops | -0.38 | -0.38 | -0.71 | -0.79 | -0.60 |
| EBITDA(a) | $-17,222 | $-15,719 | $-16,737 | $-18,551 | $-14,065 |